Skip to Content
MilliporeSigma
  • Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction.

Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction.

Stem cell research & therapy (2017-04-30)
Arantxa Blázquez-Prunera, José María Díez, Rodrigo Gajardo, Salvador Grancha
ABSTRACT

Mesenchymal stem cells (MSCs) show promising characteristics for their use in advanced therapy medicinal products. However, there are some unresolved concerns, such as the use of animal components for their expansion. In this study we assessed the suitability of a xeno-free supplement for cell culture (SCC) derived from human plasma, to culture and expand human MSCs (hMSCs) from different origins. Characteristics of viable cultured hMSCs such as genetic stability, phenotype and multipotentiality were qualitatively evaluated. hMSCs from adipose tissue (AT), bone marrow (BM) and umbilical cord (UC) and supplier sources (commercial/non-commercial) were used. After hMSCs expansion in a xeno-free medium, classical hMSCs markers were studied by immunocytochemistry, and genetic stability was tested by classic karyotyping. The capacity of hMSCs to differentiate into adipogenic, osteogenic, and chondrogenic cells in differentiation media was assessed using different staining. Different lots of SCC were used to assure consistency between batches. All hMSCs tested maintained their morphology and adherence to plastic during their expansion, and preserved their genetic stability, phenotype and differentiation potential. No differences were observed when using different lots of SCC. Moreover, the proliferation rate, evaluated as population doubling time (PDT) of commercial BM and AT hMSCs, was higher in the xeno-free medium than in the control media provided by the suppliers of the cells (PDT of 4.6 for BM-hMSC and 6.4 for AT-hMSC in xeno-free medium, and 7.0 and 14.7 respectively in the commercial media). UC-hMSCs PDT was similar in all the media tested. When using non-commercial BM-hMSCs, PDT was lower in the xeno-free medium, but reverted to the control level with the addition of growth factors. SCC-containing medium can be a feasible xeno-free alternative to expand hMSCs for advanced therapies.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Human B cells (CD19) Antibody, clone FMC63, clone FMC63, Chemicon®, from mouse
Sigma-Aldrich
Donkey Anti-Mouse IgG Antibody, FITC conjugate, Species Adsorbed, Chemicon®, from donkey
Sigma-Aldrich
Anti-STRO-1 Antibody, clone STRO-1, ascites fluid, clone STRO-1, Chemicon®
Sigma-Aldrich
Oil Red O, certified by the Biological Stain Commission
Sigma-Aldrich
Anti-Thy-1 Antibody, clone F15-42-1, clone F15-42-1, Chemicon®, from mouse
Sigma-Aldrich
Goat Anti-Mouse IgM Antibody, µ chain, Cy3 conjugate, Chemicon®, from goat
Sigma-Aldrich
Anti-Endoglin (CD105) Antibody, clone 44G4, clone 44G4, from mouse
Sigma-Aldrich
Anti-CD14 Antibody, clone 2D-15C, clone 2D-15C, Chemicon®, from mouse
Sigma-Aldrich
Anti-H-CAM Antibody, clone F10-44-2, clone F10-44-2, Chemicon®, from mouse